Ophthalmic Bottles Introduced by Berry Global | Precise Treatments to Get Easier

Published: 19 Nov 2024

Author: Precedence Research

Share :

Berry Global launched the improved 10ml ophthalmic bottle termed ‘easy squeeze’ meant for the Aptar Pharma ophthalmic squeeze dispenser (OSD) that is used for products without preservatives including eye treatments. The bottle is made of LDPE and comes in two product variations – a 10ml hybrid and soft with the latter boasting a low squeeze force for easier usage. The firm claims the pocket-size design is the most user-friendly and fast flow controlled to allow accurate dispensing of drops. 

Both types are produced according to GMP requirements in cleanroom ISO 7 at the Offranville, France-based production factory. Every single bottle goes through extensive automatic testing for important quality parameters like leakage and contour tests and is passed for gamma and eto sterilization. The advanced facilities of Berry give rise to limited batch dependencies and attack lead times. 

The new bottle was developed to easily integrate with OSD thereby ensuring precise placement of the formulation in the eye of the patient. Aptar Beauty recently developed a neo-dropper packaging in response to the evolution of more complex concentrated formulas for precise application. As a healthcare industry offering, Berry recently launched a new series of clarified polypropylene (PP) bottles which are claimed to cut down CO2 emissions by about 71% and enhance recyclability over the standard colored PET pill bottles.

Latest Announcement by Industry Leader for Ophthalmic Packaging 

Eric Green, CEO of West Pharmaceutical Services, recently shared his views on the growing demand for advanced medical packaging solutions. 

Green noted that the medical packaging sector, particularly ophthalmic packaging, is experiencing strong growth due to increased healthcare access, more chronic diseases, and innovations in drug delivery systems.

Ron Delia, CEO of Amcor, announced the company’s strong commitment to sustainability in medical packaging, including ophthalmic packaging. 

Delia explained that Amcor is investing heavily in research and development to create recyclable and sustainable packaging solutions that do not compromise the quality or safety of medical products.

Ophthalmic Packaging Market Size and Growth

The global ophthalmic packaging market size is predicted to increase from USD 6.81 billion in 2023 to approximately USD 13.83 billion by 2032, poised to grow at a CAGR of 8.2% from 2024 to 2032. North America dominated the global market with the largest market share of 36.85% in 2023.

What Does the Industry Focus on?

The ophthalmic packaging market refers to the commercial sector that designs, supplies and sells packaging materials for ophthalmic products and devices which include drugs, surgical instruments and medical apparatus. Its main goal is to protect the packaged product, maintain its sterility state, and the above includes several shapes and sizes such as; vials, bottles, ampoules, blister packs, tubes, cartons, labels among others. The market is driven by the increasing prevalence of eye disorders, need for sophisticated products, high regulatory policies, the growing geriatric population and use of contact lenses and vision correction aids.

• The WHO report predicts a projected 195.6 million-243.4 million individuals with age-related macular degeneration and glaucoma between 2020-2030, and 76 million-95.4 million with glaucoma.

Ophthalmic Packaging Industry Highlights: Challenges and Innovations in 2024 

• Environmental Concerns and Solutions: Due to the advancement in science, concern about packaging has also increased. Finding out how to manage the packaging elements in such a way that they are biodegradable but also up to safety and sterility standards.
• Preservative-Free Medicines: Novel ways to keep containers closed and clean have been pioneered with the development of closure systems and bottles that are sterilized and do not require preservatives, enhancing the tolerance to the medicine.
• The Era of Smart Technology: A growing category of smart devices that have been designed to ensure that the user takes the drug and takes appropriate doses at specified times.
• Accessibility and Inclusiveness: Package solutions that are ergonomic and easy to handle are very important in the use of ophthalmic medicine in patients without supervision.

Ophthalmic Packaging Industry Leading Players

• Amcor
• West Pharmaceutical Services, Inc.
• Gerresheimer AG
• SCHOTT AG
• AptarGroup, Inc.
• Akorn, Inc.
• Johnson & Johnson Vision
• Mitotech, SA
• Bausch & Lomb Incorporated
• AERIE PHARMACEUTICALS, INC.
• Novartis AG
• Merck Sharp & Dohme Corp.
• Bayer AG
• F. Hoffmann-La Roche Ltd.
• ALLERGAN
• Santen Pharmaceutical Co.
• Teva Pharmaceutical Industries Ltd.

Recent Breakthroughs by Ophthalmic Packaging Players Across the Globe

• In July 2024, Blow-fill-seal technology, a crucial aspect of pharmaceutical manufacturing, was introduced as a new frontier in sterile packaging, enabling the packaging of sterile liquid medications, including ophthalmic and respiratory drugs.
• In January 2024, the US FDA published draft guidance, revising a version published in December 2023, which discussed quality considerations for topical ophthalmic drug products, including extractable and leachable testing, impurities, and degradation products, and was revised from a previous version.

We’ve prepared a service to support you. please feel free to contact us at sales@precedenceresearch.com | +1 804 441 9344